Johnson & Johnson Won UK Approval for Its Psoriasis Pill. Here’s Where the Stock Could Go by 2030
Key Stats for Johnson & Johnson StockCurrent Price: $263. 81Target Price (Mid): ~$342Street Target: ~$279Potential Total Return: ~30%Annualized IRR: ~6% / year__Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)__ >>> What Happened?Johnson & Johnson (JNJ) closed at $263.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo